Metropolitan Life Insurance CO Nkarta, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$5.59 - $15.71 $9,223 - $25,921	1,650 New	1,650 $17,000
Q2 2023 Aug 10, 2023	BUY	$2.19 - $5.17 $3,545 - $8,370	1,619 Added 778.37%	1,827 $4,000
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $5,991 - $11,201	-1,778 Reduced 89.53%	208 $0
Q4 2022 Jun 14, 2023	BUY	$5.14 - $14.35 $9,138 - $25,514	1,778 Added 854.81%	1,986 $11.9 Million
Q3 2022 Jun 14, 2023	BUY	$12.27 - $18.39 $21,816 - $32,697	1,778 Added 854.81%	1,986 $26.1 Million
Q2 2022 Jun 20, 2023	BUY	$7.77 - $19.44 $13,815 - $34,564	1,778 Added 854.81%	1,986 $24,000
Q2 2022 Mar 30, 2023	SELL	$7.77 - $19.44 $15,128 - $37,849	-1,947 Reduced 49.5%	1,986 $24,000
Q2 2022 Aug 11, 2022	BUY	$7.77 - $19.44 $15,431 - $38,607	1,986 New	1,986 $24,000
Q4 2021 Feb 15, 2022	SELL	$12.79 - $26.88 $50,303 - $105,719	-3,933 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$26.67 - $38.76 $99,345 - $144,381	3,725 Added 1790.87%	3,933 $109,000
Q3 2021 Mar 30, 2023	SELL	$26.67 - $38.76 $63,207 - $91,861	-2,370 Reduced 37.6%	3,933 $109,000
Q3 2021 Nov 15, 2021	SELL	$26.67 - $38.76 $63,207 - $91,861	-2,370 Reduced 37.6%	3,933 $109,000
Q2 2021 Jun 21, 2023	BUY	$23.94 - $36.68 $145,914 - $223,564	6,095 Added 2930.29%	6,303 $199,000
Q2 2021 Mar 30, 2023	BUY	$23.94 - $36.68 $11,754 - $18,009	491 Added 8.45%	6,303 $199,000
Q2 2021 Aug 16, 2021	BUY	$23.94 - $36.68 $150,750 - $230,973	6,297 Added 104950.0%	6,303 $200,000
Q1 2021 Jun 26, 2023	BUY	$31.33 - $59.61 $175,573 - $334,054	5,604 Added 2694.23%	5,812 $191 Million
Q1 2021 Mar 30, 2023	BUY	$31.33 - $59.61 $26,285 - $50,012	839 Added 16.87%	5,812 $191,000
Q1 2021 May 14, 2021	SELL	$31.33 - $59.61 $155,616 - $296,082	-4,967 Reduced 99.88%	6 $191,000
Q4 2020 Jun 22, 2023	BUY	$27.03 - $75.62 $128,797 - $360,329	4,765 Added 2290.87%	4,973 $305,000
Q3 2020 Jun 26, 2023	BUY	$23.52 - $47.9 $112,072 - $228,243	4,765 Added 2290.87%	4,973 $149,000
Q3 2020 Mar 30, 2023	BUY	$23.52 - $47.9 $70,254 - $143,077	2,987 Added 150.4%	4,973 $149,000
Q3 2020 Nov 13, 2020	BUY	$23.52 - $47.9 $116,964 - $238,206	4,973 New	4,973 $149,000

Others Institutions Holding NKTX

# of Institutions

129

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

Ra Capital Management, L.P. Boston, MA

10.8M
Shares

$32.3 Million
0.68% of portfolio
Commodore Capital LP New York, NY

4.66M
Shares

$13.9 Million
1.79% of portfolio
Black Rock Inc. New York, NY

4.06M
Shares

$12.1 Million
0.0% of portfolio
Boxer Capital, LLC San Diego, CA

4.03M
Shares

$12 Million
0.97% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

3.77M
Shares

$11.3 Million
9.87% of portfolio

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $145M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account